Status:
COMPLETED
The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital
Lead Sponsor:
West China Hospital
Conditions:
Primary Biliary Cholangitis
Eligibility:
All Genders
25-85 years
Brief Summary
This study evaluates the different response of Ursodeoxycholic Acid in primary biliary cholangitis only and primary biliary cholangitis with high immune globulin G or aminotransferase at West China Ho...
Eligibility Criteria
Inclusion
- Patients diagnosed with primary biliary cholangitis Treated with Ursodeoxycholic Acid in West China Hospital for at least 1 year
Exclusion
- Autoimmune hepatitis Primary sclerosing cholangitis
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03322943
Start Date
January 1 2016
End Date
December 30 2018
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital
Chengdu, Sichuan, China, 610041